Canada Life’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-107,627
Closed -$111K 2263
2023
Q2
$111K Buy
107,627
+1,870
+2% +$1.74K ﹤0.01% 1912
2023
Q1
$143K Buy
105,757
+57,106
+117% +$81.6K ﹤0.01% 1921
2022
Q4
$75K Buy
48,651
+23,163
+91% +$51.7K ﹤0.01% 2027
2022
Q3
$74K Buy
25,488
+5,180
+26% +$14.1K ﹤0.01% 2040
2022
Q2
$37K Buy
20,308
+10,289
+103% +$30.3K ﹤0.01% 2117
2022
Q1
$46K Buy
10,019
+602
+6% +$2.7K ﹤0.01% 2174
2021
Q4
$51K Buy
9,417
+570
+6% +$5.32K ﹤0.01% 2167
2021
Q3
$122K Hold
8,847
﹤0.01% 2013
2021
Q2
$145K Sell
8,847
-2,087
-19% -$31.1K ﹤0.01% 2008
2021
Q1
$207K Buy
10,934
+7,749
+243% +$112K ﹤0.01% 1942
2020
Q4
$20K Hold
3,185
﹤0.01% 2542
2020
Q3
$9K Hold
3,185
﹤0.01% 2530
2020
Q2
$14K Hold
3,185
﹤0.01% 2549
2020
Q1
$8K Hold
3,185
﹤0.01% 2539
2019
Q4
$10K Buy
+3,185
New +$11.8K ﹤0.01% 2582
2019
Q3
Sell
-6,002
Closed -$21K 2453
2019
Q2
$21K Buy
+6,002
New +$23.6K ﹤0.01% 2582

Other funds holding AMRS

Canada Life's AMRS Position: Q3 2023 in Review

Canada Life sold out of Amyris Inc. (AMRS) in Q3 2023, closing a stake of 107,627 shares — an estimated $111K sold.

Canada Life first reported a position in AMRS in Q2 2019 and held it in 16 quarters. The position peaked at $207K in Q1 2021. 18 funds tracked by Wall St. Rank hold AMRS as of Q3 2023.

  • Canada Life reported no remaining Amyris Inc. position as of Q3 2023 after selling out during the quarter.
  • Canada Life sold 107,627 Amyris Inc. shares in Q3 2023, an estimated $111K.
  • Canada Life first reported a position in Amyris Inc. in Q2 2019 and held it in 16 quarters.
  • Canada Life's Amyris Inc. position peaked at $207K in Q1 2021.
  • 18 funds tracked by Wall St. Rank held Amyris Inc. as of Q3 2023.

Based on Canada Life's 13F filing for Q3 2023, filed 14 Nov 2023.